Skip to content

BIO International Convention

Quote icon


Learn more


28-30 June 2022, Santa Clara Convention Center


Meet PL at BIO23-min

 Boston, MA      5-8 June 2023

We're attending BIO International Convention 2023 to discuss strategic R&D collaborations with biopharma partners that share our commitment to developing better, more personalized treatments for patients.

With high resolution insights and patient stratification biomarkers in over 45 complex diseases, we've now developed the largest drug discovery pipeline of precision targeted therapies in areas of unmet medical need, ready to discuss with you at BIO.

Our approach:

We generate the deepest disease biology insights and enable detailed mechanistic patient stratification in highly heterogeneous diseases.

  • Informing drug discovery with novel targets matched to patient biology to optimize selection of the right targets and product profiles
  • Derisking clinical development with biomarkers of drug response to design targeted clinical trials with a greater probability of success
  • Accelerating drug approvals and deployment with precision diagnostics and risk scores to prescribe new therapies to the patients who will benefit from them.

Meet our team at BIO 2023:

  • Steve Gardner, Chief Executive Officer and Co-founder
  • Rowan Gardner, Chief Business & Investment Officer and Co-founder
  • Simon Beaulah, SVP Healthcare & Head of US Operations


Recent news:

Message us in the BIO Partnering Platform or contact us to setup a meeting.

Partner at BIO

Sign up to our newsletter for the latest resources & news

Follow us for the latest news updates

Press contact

"This is a quote about something or other, test da ba dee da ba doo. Lorem Ispum Lorem Ipsum"

Name Surname, Position, Company

Sign up to our newsletter for the latest resources & news

Be kept informed of our work

Follow us for the latest news updates

Press contact

Charles Consultants

Sue Charles

+44 (0)7968 726585

Contact us

Contact us to discuss potential collaborations and partnering opportunities.